TAJMAH I KELLEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PHILADELPHIA, PA NPI 1962846501
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family PA Amgen Inc. All categories
General Payments — all program years on this page
$716.81
- Category: General Payments
- Program years: PY2021–2024
- Record count: 30
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $331.70 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.70 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $147.15 | 3 |
| Abbott Laboratories | $99.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $23.97 | 1 |
| ABIOMED | $23.91 | 1 |
| Janssen Pharmaceuticals, Inc | $21.30 | 1 |
| Acerta Pharma LLC | $15.69 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078156413 | Janssen Pharmaceuticals, Inc | $21.30 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101650258 | E.R. Squibb & Sons, L.L.C. | $23.97 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104770482 | AstraZeneca Pharmaceuticals LP | $15.69 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117294573 | Amgen Inc. | $13.97 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117294575 | Amgen Inc. | $128.32 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117595940 | Amgen Inc. | $4.86 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125362138 | Abbott Laboratories | $99.68 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142281810 | ABIOMED | $23.91 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.